Subscribe
Machinery
Design
Newsletters
Machine Tours
Eli Lilly and Company
More from Eli Lilly and Company
Home
Applying Modern Technology to Pharmaceutical Production Facilities
Robotics, biometrics, and isolator technology are proving cleaner, faster, and safer than traditional manual methods.
Home
Applying Modern Technology to Pharmaceutical Production Facilities
Robotics, biometrics, and isolator technology are proving cleaner, faster, and safer than traditional manual methods.
Home
Walmart, Walgreens Join MediLedger to Fight Counterfeit Drugs
The retail behemoths have joined the blockchain pharma supply chain project aimed at tackling the counterfeit drug market.
Home
Brexit Contingency Plans for Pharma Industry
The EU currently supplies two-thirds of the medicines in the UK. How will Brexit affect pharmaceutical investments and manufacturing?
Home
Trump Nominates Alex Azar for HHS Secretary
President Trump picks former Eli Lilly executive to “be a star for better healthcare and lower drug prices!”
Home
Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017
Significant investment in manufacturing diabetes medicines continues with new $85 million commitment in Indianapolis; $5 billion invested in its U.S. operations over the last decade; more favorable tax climate could lead to additional U.S. investments.
Home
Top 10 Patent Cliffs of 2017
Patent expiration is clearing a path for generics to take over; here’s a look at the top 10 patents expiring this year.
Home
Trump to Pharma: Lower Prices & Fewer Regulations
President Trump met with Big Pharma players to discuss lowering prices and bringing drug manufacturing back to the U.S.
Home
Eli Lilly compliance pack earns honors
The 2014 HCPC Compliance Package of the Year First Runner Up was awarded to the Eli Lilly Strattera® Physician Sample Pack from PCI, which contains medication for the treatment of attention-deficit/hyperactivity disorder (ADHD).
